179 related articles for article (PubMed ID: 23177609)
21. [The treatment of acute ischemic stroke].
Csiba L
Orv Hetil; 2004 Nov; 145(45):2297-301. PubMed ID: 15573895
[No Abstract] [Full Text] [Related]
22. Local intra-arterial thrombolysis with urokinase for acute ischemic stroke before and after the approval of intravenous tissue plasminogen activator treatment in Taiwan.
Yang FC; Lin CC; Hsueh CJ; Lee JT; Hsu CH; Lee KW; Peng GS
Ann Vasc Surg; 2010 Nov; 24(8):1117-24. PubMed ID: 21035704
[TBL] [Abstract][Full Text] [Related]
23. Plasminogen activation and thrombolysis for ischemic stroke.
Medcalf RL; Davis SM
Int J Stroke; 2012 Jul; 7(5):419-25. PubMed ID: 22463085
[TBL] [Abstract][Full Text] [Related]
24. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy.
Toni D; Lorenzano S; Agnelli G; Guidetti D; Orlandi G; Semplicini A; Toso V; Caso V; Malferrari G; Fanucchi S; Bartolomei L; Prencipe M
Cerebrovasc Dis; 2008; 25(1-2):129-35. PubMed ID: 18073466
[TBL] [Abstract][Full Text] [Related]
25. [Intravenous thrombolytic therapy of patients with acute cerebral infarction].
Thomassen L; Sandset PM; Joakimsen O; Indredavik B; Russell D
Tidsskr Nor Laegeforen; 2003 Mar; 123(5):638-9. PubMed ID: 12683192
[No Abstract] [Full Text] [Related]
26. Current acute stroke trials and their potential impact on the therapeutic time window.
Schellinger PD; Köhrmann M
Expert Rev Neurother; 2012 Feb; 12(2):169-77. PubMed ID: 22288672
[TBL] [Abstract][Full Text] [Related]
27. Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA).
Eissa A; Krass I; Bajorek BV
J Clin Pharm Ther; 2012 Dec; 37(6):620-9. PubMed ID: 22708668
[TBL] [Abstract][Full Text] [Related]
28. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes.
Fonarow GC; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Grau-Sepulveda MV; Olson DM; Hernandez AF; Peterson ED; Schwamm LH
Circulation; 2011 Feb; 123(7):750-8. PubMed ID: 21311083
[TBL] [Abstract][Full Text] [Related]
29. Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
Fitzpatrick AE; Noone I; O'Shea DD
N Engl J Med; 2008 Dec; 359(26):2840; author reply 2841. PubMed ID: 19115491
[No Abstract] [Full Text] [Related]
30. Thrombolytic therapy for acute ischemic stroke: risks vs benefits.
Lindbloom EJ
J Fam Pract; 2003 Oct; 52(10):757, 761. PubMed ID: 14529595
[No Abstract] [Full Text] [Related]
31. Intra-arterial thrombolysis: tissue plasminogen activator and other thrombolytic agents.
Samaniego EA; Linfante I; Dabus G
Tech Vasc Interv Radiol; 2012 Mar; 15(1):41-6. PubMed ID: 22464301
[TBL] [Abstract][Full Text] [Related]
32. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
Seet RC; Rabinstein AA
Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
[TBL] [Abstract][Full Text] [Related]
33. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
Masrur S; Abdullah AR; Smith EE; Hidalgo R; El-Ghandour A; Rordorf G; Schwamm LH
J Stroke Cerebrovasc Dis; 2011; 20(2):124-30. PubMed ID: 20598579
[TBL] [Abstract][Full Text] [Related]
34. Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis.
Maiser SJ; Georgiadis AL; Suri MF; Vazquez G; Lakshminarayan K; Qureshi AI
Int J Stroke; 2011 Feb; 6(1):25-32. PubMed ID: 21205237
[TBL] [Abstract][Full Text] [Related]
35. Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke.
Lin CB; Peterson ED; Smith EE; Saver JL; Liang L; Xian Y; Olson DM; Shah BR; Hernandez AF; Schwamm LH; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):514-22. PubMed ID: 22787065
[TBL] [Abstract][Full Text] [Related]
36. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
[TBL] [Abstract][Full Text] [Related]
37. The use and misuse of thrombolytic therapy within the Veterans Health Administration.
Keyhani S; Arling G; Williams LS; Ross JS; Ordin DL; Myers J; Tyndall G; Vogel B; Bravata DM
Med Care; 2012 Jan; 50(1):66-73. PubMed ID: 22182924
[TBL] [Abstract][Full Text] [Related]
38. Treatment of acute ischemic stroke.
Lewandowski C; Barsan W
Ann Emerg Med; 2001 Feb; 37(2):202-16. PubMed ID: 11174240
[TBL] [Abstract][Full Text] [Related]
39. [Thrombolytic therapy in stroke approved with reservation. Underlying evidence, practical guidelines and safety follow up].
Wahlgren NG
Lakartidningen; 2004 Feb; 101(8):674-7. PubMed ID: 15024940
[No Abstract] [Full Text] [Related]
40. Endovascular treatment strategies for acute ischemic stroke.
Ellis JA; Youngerman BE; Higashida RT; Altschul D; Meyers PM
Int J Stroke; 2011 Dec; 6(6):511-22. PubMed ID: 22111796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]